NABILONE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for nabilone and what is the scope of freedom to operate?

Nabilone is the generic ingredient in one branded drug marketed by Bausch and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for nabilone. One supplier is listed for this compound.

Summary for NABILONE

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	19
Clinical Trials:	35
Patent Applications:	4,745
What excipients (inactive ingredients) are in NABILONE?	NABILONE excipients list
DailyMed Link:	NABILONE at DailyMed

Recent Clinical Trials for NABILONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Centre for Addiction and Mental Health	Phase 4
Simon Ducharme, MD	Phase 3
PleoPharma, Inc.	Phase 2

See all NABILONE clinical trials

Pharmacology for NABILONE

Drug Class	Cannabinoid

Anatomical Therapeutic Chemical (ATC) Classes for NABILONE

A04AD	Other antiemetics
A04A	ANTIEMETICS AND ANTINAUSEANTS
A04	ANTIEMETICS AND ANTINAUSEANTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for NABILONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NABILONE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	⤷ Sign Up	⤷ Sign Up
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	⤷ Sign Up	⤷ Sign Up
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.